Cover Image
Read Now

Future research needs for first- and second-generation antipsychotics for children and young adults

This future research needs (FRN) report is based on an Agency for Healthcare Research and Quality (AHRQ) comparative effectiveness review (CER) titled "First- and Second-Generation Antipsychotics for Children and Young Adults." The purpose of the CER was to review and synthesize the eviden...

Full description

Bibliographic Details
Main Author: Christian, Robert B.
Corporate Authors: Effective Health Care Program (U.S.), United States Agency for Healthcare Research and Quality, Research Triangle Institute-University of North Carolina Evidence-based Practice Center
Format: eBook
Language:English
Published: Rockville, MD Agency for Healthcare Research and Quality [2012], 2012
Series:Future research needs papers
Subjects:
Comparative Effectiveness Research
Child
Young Adult
Evidence-based Medicine
Antipsychotic Agents / Adverse Effects
Mental Disorders / Drug Therapy
Antipsychotic Agents / Therapeutic Use
Forecasting
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:This future research needs (FRN) report is based on an Agency for Healthcare Research and Quality (AHRQ) comparative effectiveness review (CER) titled "First- and Second-Generation Antipsychotics for Children and Young Adults." The purpose of the CER was to review and synthesize the evidence regarding the benefits and harms of first- and second-generation antipsychotics (FGAs and SGAs) for the treatment of various psychiatric and behavioral conditions in individuals 24 years of age or younger
Item Description:"February 2012."
Physical Description:1 PDF file (various pagings)

Similar Items